NCT04830046 2025-11-26
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Massachusetts General Hospital
Completed
Clinical Trials
16 trialsNCT05386355 2025-03-11
MoVeUP
IDeA States Pediatric Clinical Trials Network
Phase NA Completed
NCT04466098 2025-01-29
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT05422937 2024-05-22
SPLaT-19
Keele University
Completed
NCT04666025 2024-04-08
SARS-CoV-2 Donor-Recipient Immunity Transfer
City of Hope Medical Center
Completed
NCT04358406 2023-11-28
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Phase 2 Completed
NCT05303376 2023-09-13
Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness
Immune Biosolutions Inc
Phase 1/2 Completed
NCT05827341 2023-06-18
A Real-World Study of COVID-19 Infection in Patients With Malignant Lymphomas Participating in Clinical Trials
Sun Yat-sen University
Completed
NCT04733833 2023-02-01
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Vascular Biogenics Ltd. operating as VBL Therapeutics
Phase 2 Completed
NCT04422470 2023-01-26
CHRONOS19
National Research Center for Hematology, Russia
Completed
NCT04330261 2022-05-17
PERN-COVID-19
University of Calgary
Completed
NCT04453384 2022-03-25
POLYCOR
Nantes University Hospital
Phase 2 Completed
NCT04760184 2022-02-08
AutoCOVID-19
Uppsala University
Completed
NCT04477655 2021-04-13
PRO-CARF
Hospital Civil de Guadalajara
Phase NA Completed
NCT04745416 2021-02-09
Clinical Characteristics of Patients With Leukemia and COVID-19
Hospital General de Mexico
Completed
NCT04564040 2020-12-29
A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole
AstraZeneca
Phase 1 Completed